Literature DB >> 23207168

The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases.

Kleoniki Roka1, Eleftheria Roma, Kalliopi Stefanaki, Ioanna Panayotou, Giannis Kopsidas, Giorgos Chouliaras.   

Abstract

BACKGROUND AND AIMS: Focally enhanced gastritis (FEG) has been suggested as a diagnostic marker for patients with Crohn's disease. In this study we evaluated the prevalence of FEG in children with inflammatory bowel diseases (IBD) and assessed the ability of FEG to distinguish IBD from non-IBD patients.
METHODS: A retrospective study of the children who underwent esophagogastroduodenal endoscopy (EGD) during 2004-2011 was performed, after excluding individuals with H. pylori infection and celiac disease. Two groups were studied: patients with IBD (IBD group, n=185) and non-IBD patients who underwent endoscopy of the upper gastrointestinal tract for various abdominal complaints (non-IBD group, n=684). Relation of FEG to age and gender was also assessed.
RESULTS: FEG was found significantly more frequently among children with IBD (35.7% vs 3.4%, respectively, p<0.001). Children with FEG were 15.4 times more likely to have IBD than to belong in the non-IBD group. All types of IBD had significantly higher frequencies of FEG compared to non-IBD individuals (Crohn's disease: 54.1%, ulcerative colitis: 21.6%, IBD unclassified: 18.4%, all three comparisons with the non-IBD group: p-values<0.001). FEG positivity was more common in females compared to males with Crohn's disease and ulcerative colitis and in children younger than 2 years in the IBD-unspecified group. FEG achieved a sensitivity of 35.7% and specificity of 96.6% in distinguishing between IBD from non-IBD patients.
CONCLUSIONS: FEG has significantly higher prevalence in children with IBD, particularly Crohn's disease and can be a valuable supporting finding in cases of indefinite diagnosis.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD; Crohn's disease; FEG; Focally enhanced gastritis; IBD; Inflammatory bowel disease; Inflammatory bowel disease unclassified; NPV; PPV; Prognostic factors; UC; Ulcerative colitis; negative predictive value; positive predictive value

Mesh:

Year:  2012        PMID: 23207168     DOI: 10.1016/j.crohns.2012.11.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  13 in total

1.  Focally enhanced gastritis in newly diagnosed pediatric inflammatory bowel disease.

Authors:  Tetsuo Ushiku; Christopher J Moran; Gregory Y Lauwers
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

2.  IBD: Focally enhanced gastritis could help in the diagnosis of paediatric IBD.

Authors:  Isobel Franks
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-18       Impact factor: 46.802

Review 3.  Diagnostic dilemmas in chronic inflammatory bowel disease.

Authors:  Maurice B Loughrey; Neil A Shepherd
Journal:  Virchows Arch       Date:  2017-11-04       Impact factor: 4.064

4.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 5.  Crohn's Disease of the Esophagus, Duodenum, and Stomach.

Authors:  David M Schwartzberg; Stephen Brandstetter; Alexis L Grucela
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

Review 6.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

7.  Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations.

Authors:  Yiyoung Kwon; Eun Sil Kim; Yon Ho Choe; Mi Jin Kim
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

Review 8.  Helicobacter pylori infection and inflammatory bowel disease: is there a link?

Authors:  Konstantinos Papamichael; Panagiotis Konstantopoulos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

9.  Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.

Authors:  Adi Lahat; Uri Kopylov; Sandra Neuman; Nina Levhar; Doron Yablecovitch; Benjamin Avidan; Batia Weiss; Shomron Ben-Horin; Rami Eliakim
Journal:  BMC Gastroenterol       Date:  2017-02-13       Impact factor: 3.067

Review 10.  Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review.

Authors:  Yan Sun; Zhe Zhang; Chang-Qing Zheng; Li-Xuan Sang
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.